Literature DB >> 28825167

Application of cryoenergy to improve septal exposure during transaortic septal myectomy in hypertrophic obstructive cardiomyopathy.

Alberto Pozzoli1, Luca Vicentini2, Stefan Thelin3, Elisabetta Lapenna2, Leif Nilsson3, Ottavio Alfieri2.   

Abstract

For the past few decades, the transaortic septal myectomy (Morrow's procedure) has been the gold standard for treating severe left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy (HOCM) patients. 30-day mortality has been reported at less than 1% in dedicated centers. However, in a subgroup of patients, the interventricular septal obstruction is localized very distally, below the aortic valve plane, and the transaortic approach can be very challenging. A subset of these patients can present with residual obstruction after surgery, due to inadequate length of septal excision, leading to reoperation. The aim of this work is to illustrate an original application of cryoenergy to improve the transaortic exposure of the interventricular septum and thus enable surgeons to perform very distal myectomies in HOCM patients.

Entities:  

Keywords:  Cryoenergy; Hypertrophic cardiomyopathy; Residual left ventricular outflow tract obstruction; Transaortic myectomy

Mesh:

Year:  2017        PMID: 28825167     DOI: 10.1007/s11748-017-0815-8

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  3 in total

1.  Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction.

Authors:  Barry J Maron; Joseph A Dearani; Steve R Ommen; Martin S Maron; Hartzell V Schaff; Rick A Nishimura; Anthony Ralph-Edwards; Harry Rakowski; Mark V Sherrid; Daniel G Swistel; Sandhya Balaram; Hassan Rastegar; Ethan J Rowin; Nicholas G Smedira; Bruce W Lytle; Milind Y Desai; Harry M Lever
Journal:  J Am Coll Cardiol       Date:  2015-09-15       Impact factor: 24.094

2.  Excision of anomalous muscle bundles as an important addition to extended septal myectomy for treatment of left ventricular outflow tract obstruction.

Authors:  Shuiyun Wang; Hao Cui; Qinjun Yu; Haibo Chen; Changsheng Zhu; Jingjin Wang; Minghu Xiao; Yanbo Zhang; Rong Wu; Shengshou Hu
Journal:  J Thorac Cardiovasc Surg       Date:  2016-02-17       Impact factor: 5.209

3.  Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy-mechanisms of obstruction and outcomes of reoperation.

Authors:  Yang Hyun Cho; Eduard Quintana; Hartzell V Schaff; Rick A Nishimura; Joseph A Dearani; Martin D Abel; Steve Ommen
Journal:  J Thorac Cardiovasc Surg       Date:  2014-05-16       Impact factor: 5.209

  3 in total
  1 in total

Review 1.  Septal Ablation Versus Surgical Myomectomy for Hypertrophic Obstructive Cardiomyopathy.

Authors:  F Pelliccia; H Seggewiss; F Cecchi; P Calabrò; G Limongelli; O Alfieri; P Ferrazzi; M H Yacoub; I Olivotto
Journal:  Curr Cardiol Rep       Date:  2021-10-01       Impact factor: 2.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.